| Literature DB >> 28279342 |
Abstract
Recent studies demonstrate that the Ebola virus glycoprotein (GP) acquired an A82V change during the West Africa epidemic and that this change altered the capacity of GP to be activated by host factors, enhancing infection of human cells. How this may alter the outcome of disease remains to be determined.Entities:
Mesh：
Substances：
Year: 2017 PMID： 28279342 DOI： 10.1016/j.chom.2017.02.017
Source DB: PubMed Journal: Cell Host Microbe ISSN： 1931-3128 Impact factor: 21.023